Close

News

Sanofi to acquire Principia Biopharma

Sanofi and Principia Biopharma Inc., a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash,...

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.

Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (JHM), to develop a CDx that will leverage the Oncomine Precision Assay,...

COVID-19: Potential Vaccines and Logistics

While pharmaceuticals contribute to approximately 2% of annual air cargo volume, the industry transports over one trillion dollars’ worth of cargo every year (IATA). Pharmaceutical shipments have an overwhelmingly large impact on the global response to infectious diseases and...

China grants country’s first Covid-19 vaccine patent to CanSino

China's vaccine maker CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, People's Daily reported, citing documents from the country's intellectual property regulator. The patent was submitted for application on March 18,...

Covaxin: Bharat Biotech-ICMR developed vaccine is safe, show preliminary results

The preliminary results of phase 1 clinical trials of Bharat Biotech-ICMR developed Covaxin, a COVID-19 vaccine, has shown that the vaccine is safe. The results were informed by the principal investigators who have been conducting the trials of the...

Russia’s COVID-19 vaccine to enter production, deliver first batch of doses in two weeks

The world's first vaccine registered by Russian authorities, and now the World Health Organisation has said it is in talks with Russia's health ministry for a thorough review of the safety and efficacy of the vaccine, called Sputnik V. While...

TIACA and Pharma.Aero Join Forces to Prepare Air Cargo Industry for COVID-19 Vaccine

The International Air Cargo Association (TIACA) and Pharma.Aero have joined forces to develop global guidance for the air cargo industry to enable optimal transportation of the COVID-19 vaccine. The guidance will be developed gradually in four work packages through...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read